132 related articles for article (PubMed ID: 23954626)
1. Extracellular alpha-synuclein induces calpain-dependent overactivation of cyclin-dependent kinase 5 in vitro.
Czapski GA; Gąssowska M; Wilkaniec A; Cieślik M; Adamczyk A
FEBS Lett; 2013 Sep; 587(18):3135-41. PubMed ID: 23954626
[TBL] [Abstract][Full Text] [Related]
2. A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5).
Kaźmierczak A; Czapski GA; Adamczyk A; Gajkowska B; Strosznajder JB
Neurochem Int; 2011 Feb; 58(2):206-14. PubMed ID: 21130128
[TBL] [Abstract][Full Text] [Related]
3. Calpain-2/p35-p25/Cdk5 pathway is involved in the neuronal apoptosis induced by polybrominated diphenyl ether-153.
Zhang H; Chang L; Zhang H; Nie J; Zhang Z; Yang X; Vuong AM; Wang Z; Chen A; Niu Q
Toxicol Lett; 2017 Aug; 277():41-53. PubMed ID: 28559121
[TBL] [Abstract][Full Text] [Related]
4. N-acetylcysteine prevents beta-amyloid toxicity by a stimulatory effect on p35/cyclin-dependent kinase 5 activity in cultured cortical neurons.
Hsiao YH; Chen PS; Yeh SH; Lin CH; Gean PW
J Neurosci Res; 2008 Sep; 86(12):2685-95. PubMed ID: 18512759
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk between cdk5 and MEK-ERK signalling upon opioid receptor stimulation leads to upregulation of activator p25 and MEK1 inhibition in rat brain.
Ramos-Miguel A; García-Sevilla JA
Neuroscience; 2012 Jul; 215():17-30. PubMed ID: 22537847
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol inhibits Cdk5 activity through regulation of p35 expression.
Utreras E; Terse A; Keller J; Iadarola MJ; Kulkarni AB
Mol Pain; 2011 Jul; 7():49. PubMed ID: 21736731
[TBL] [Abstract][Full Text] [Related]
8. Extracellular α-synuclein leads to microtubule destabilization via GSK-3β-dependent Tau phosphorylation in PC12 cells.
Gąssowska M; Czapski GA; Pająk B; Cieślik M; Lenkiewicz AM; Adamczyk A
PLoS One; 2014; 9(4):e94259. PubMed ID: 24722055
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Czeta regulates Cdk5/p25 signaling during myogenesis.
de Thonel A; Ferraris SE; Pallari HM; Imanishi SY; Kochin V; Hosokawa T; Hisanaga S; Sahlgren C; Eriksson JE
Mol Biol Cell; 2010 Apr; 21(8):1423-34. PubMed ID: 20200223
[TBL] [Abstract][Full Text] [Related]
10. Involvement of calpain/p35-p25/Cdk5/NMDAR signaling pathway in glutamate-induced neurotoxicity in cultured rat retinal neurons.
Miao Y; Dong LD; Chen J; Hu XC; Yang XL; Wang Z
PLoS One; 2012; 7(8):e42318. PubMed ID: 22870316
[TBL] [Abstract][Full Text] [Related]
11. Cyclin-dependent kinase 5 (CDK5) inhibitors in Parkinson disease.
Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alshammari MS; Alexiou A; Papadakis M; Bahaa MM; Batiha GE
J Cell Mol Med; 2024 Jun; 28(11):e18412. PubMed ID: 38842132
[TBL] [Abstract][Full Text] [Related]
12. Kainate induces AKT, ERK and cdk5/GSK3beta pathway deregulation, phosphorylates tau protein in mouse hippocampus.
Crespo-Biel N; Canudas AM; Camins A; Pallàs M
Neurochem Int; 2007 Jan; 50(2):435-42. PubMed ID: 17116346
[TBL] [Abstract][Full Text] [Related]
13. High glucose increases Cdk5 activity in podocytes via transforming growth factor-β1 signaling pathway.
Zhang Y; Li H; Hao J; Zhou Y; Liu W
Exp Cell Res; 2014 Aug; 326(2):219-29. PubMed ID: 24768698
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Phosphoproteomic Analysis in Alpha-Synuclein Transgenic Mice Reveals the Involvement of Aberrant p25/Cdk5 Signaling in Early-stage Parkinson's Disease.
He F; Qi G; Zhang Q; Cai H; Li T; Li M; Zhang Q; Chen J; Ming J; Tian B; Zhang P
Cell Mol Neurobiol; 2020 Aug; 40(6):897-909. PubMed ID: 32016637
[TBL] [Abstract][Full Text] [Related]
15. Peroxiredoxin 5 Decreases Beta-Amyloid-Mediated Cyclin-Dependent Kinase 5 Activation Through Regulation of Ca
Park J; Kim B; Chae U; Lee DG; Kam MK; Lee SR; Lee S; Lee HS; Park JW; Lee DS
Antioxid Redox Signal; 2017 Oct; 27(11):715-726. PubMed ID: 28358580
[TBL] [Abstract][Full Text] [Related]
16. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2.
Smith PD; Mount MP; Shree R; Callaghan S; Slack RS; Anisman H; Vincent I; Wang X; Mao Z; Park DS
J Neurosci; 2006 Jan; 26(2):440-7. PubMed ID: 16407541
[TBL] [Abstract][Full Text] [Related]
17. The role of CDK5/P25 formation/inhibition in neurodegeneration.
Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of aberrant cyclin-dependent kinase 5 activity attenuates isoflurane neurotoxicity in the developing brain.
Wang WY; Luo Y; Jia LJ; Hu SF; Lou XK; Shen SL; Lu H; Zhang HH; Yang R; Wang H; Ma ZW; Xue QS; Yu BW
Neuropharmacology; 2014 Feb; 77():90-9. PubMed ID: 24055498
[TBL] [Abstract][Full Text] [Related]
19. 3-Nitropropionic acid activates calpain/cdk5 pathway in rat striatum.
Crespo-Biel N; Camins A; Pelegrí C; Vilaplana J; Pallàs M; Canudas AM
Neurosci Lett; 2007 Jun; 421(1):77-81. PubMed ID: 17566644
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of arsenic-induced neurotoxicity may be explained through cleavage of p35 to p25 by calpain.
Vahidnia A; van der Straaten RJ; Romijn F; van Pelt J; van der Voet GB; de Wolff FA
Toxicol In Vitro; 2008 Apr; 22(3):682-7. PubMed ID: 18242949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]